Choosing isolates for the evaluation of meningococcal protein vaccines

被引：1

作者：

Feavers, Ian ^{[1
]}

机构：

[1] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar EN6 3QG, Herts, England

来源：

EXPERT REVIEW OF VACCINES | 2009年 / 8卷 / 11期

关键词：

FACTOR-H BINDING; SEROGROUP-B; SEQUENCE; SERUM; STANDARDIZATION; COMPLEMENT; CANDIDATE; GENES;

D O I：

10.1586/ERV.09.104

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1461 / 1463

页数：3

共 16 条

[1] Neisseria meningitidis group B correlates of protection and assay standardization -: International meeting report Emory University, Atlanta, Georgia, United States, 16-17 march 2005 [J].

Borrow, R. ;

Carlone, G. M. ;

Rosenstein, N. ;

Plikaytis, B. ;

Blake, M. ;

Feavers, I. ;

Martin, D. ;

Zollinger, W. ;

Robbins, J. ;

Aaberge, I. ;

Granoff, D. M. ;

Miller, E. ;

van Alphen, L. ;

Poolman, J. ;

Rappuoli, R. ;

Danzig, L. ;

Hackell, J. ;

Danve, B. ;

Caulfield, M. ;

Lambert, S. ;

Stephens, D. .

VACCINE, 2006, 24 (24) :5093-5107

[2] Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup B, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine [J].

Borrow, R ;

Aaberge, IS ;

Santos, GF ;

Eudey, TL ;

Oster, P ;

Glennie, A ;

Findlow, J ;

Hoiby, EA ;

Rosenqvist, E ;

Balmer, P ;

Martin, D .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (08) :970-976

[3] Meningococcal carriage and disease-Population biology and evolution [J].

Caugant, Dominique A. ;

Maiden, Martin C. J. .

VACCINE, 2009, 27 :B64-B70

[4] Meningococcal protein antigens and vaccines [J].

Feavers, Ian M. ;

Pizza, Mariagrazia .

VACCINE, 2009, 27 :B42-B50

[5] Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis group B isolates in a serum, bactericidal antibody assay [J].

Findlow, Jamie ;

Holland, Ann ;

Andrews, Nick ;

Weynants, Vincent ;

Sotolongo, Franklin ;

Balmer, Paul ;

Poolman, Jan ;

Borrow, Ray .

CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (11) :1451-1457

[6] Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease [J].

Frasch, Carl E. ;

Borrow, Ray ;

Donnelly, John .

VACCINE, 2009, 27 :B112-B116

[7] HUMAN IMMUNITY TO MENINGOCOCCUS .I. ROLE OF HUMORAL ANTIBODIES [J].

GOLDSCHNEIDER, I ;

GOTSCHLICH, EC ;

ARTENSTEIN, MS .

JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1307-+

[8] Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B [J].

Grifantini, R ;

Sebastian, S ;

Frigimelica, E ;

Draghi, M ;

Bartolini, E ;

Muzzi, A ;

Rappuoli, R ;

Grandi, G ;

Genco, CA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9542-9547

[9] Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays [J].

Grifantini, R ;

Bartolini, E ;

Muzzi, A ;

Draghi, M ;

Frigimelica, E ;

Berger, J ;

Ratti, G ;

Petracca, R ;

Galli, G ;

Agnusdei, M ;

Giuliani, MM ;

Santini, L ;

Brunelli, B ;

Tettelin, H ;

Rappuoli, R ;

Randazzo, F ;

Grandi, G .

NATURE BIOTECHNOLOGY, 2002, 20 (09) :914-921

[10] The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance [J].

Madico, Guillermo ;

Welsch, Jo Anne ;

Lewis, Lisa A. ;

McNaughton, Anne ;

Perlman, David H. ;

Costello, Catherine E. ;

Ngampasutadol, Jutamas ;

Vogel, Ulrich ;

Granoff, Dan M. ;

Ram, Sanjay .

JOURNAL OF IMMUNOLOGY, 2006, 177 (01) :501-510

← 1 2 →